Laddar...
Targeted intestinal delivery of incretin secretagogues—towards new diabetes and obesity therapies
A new strategy under development for the treatment of type 2 diabetes and obesity is to mimic some of the effects of bariatric surgery by delivering food-related stimuli to the distal gastrointestinal tract where they should enhance the release of gut hormones such as glucagon-like peptide-1 (GLP-1)...
Sparad:
| I publikationen: | Peptides |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier Science Inc
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5805852/ https://ncbi.nlm.nih.gov/pubmed/29412834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.peptides.2017.11.008 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|